Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

For more information
on BPDCN, click here



The Company
Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk.
Clinical Trials
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen to identify novel compounds that target and kill CSCs.


News
&
Events
9/23/2016
Stemline to Present at the Ladenburg Thalmann 2016 Healthcare Conference
9/7/2016
Stemline to Present at the Rodman & Renshaw 18th Annual Investment Conference
8/23/2016
Stemline Receives Breakthrough Therapy Designation from U.S. FDA
Copyright 2016 - Stemline Therapeutics, Inc. All rights reserved
Stemline